Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Three tyrosine kinase inhibitors cause cardiotoxicity by inducing endoplasmic reticulum stress and inflammation in cardiomyocytes
Huan Wang, Yiming Wang, Jiongyuan Li, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Insights into Drug Cardiotoxicity from Biological and Chemical Data: The First Public Classifiers for FDA Drug-Induced Cardiotoxicity Rank
Srijit Seal, Ola Spjuth, Layla Hosseini-Gerami, et al.
Journal of Chemical Information and Modeling (2024) Vol. 64, Iss. 4, pp. 1172-1186
Open Access | Times Cited: 18
Understanding Sorafenib-Induced Cardiovascular Toxicity: Mechanisms and Treatment Implications
Jue Li, Lusha Zhang, Teng Ge, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 829-843
Open Access | Times Cited: 11
A Comprehensive Overview on Chemotherapy-Induced Cardiotoxicity: Insights into the Underlying Inflammatory and Oxidative Mechanisms
András Nagy, Denise Börzsei, Alexandra Hoffmann, et al.
Cardiovascular Drugs and Therapy (2024)
Open Access | Times Cited: 10
Advancements in understanding cardiotoxicity of EGFR- TKIs in non-small cell lung cancer treatment and beyond
Xin Li, Yongping Lin, Lin Song, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Comprehensive review of non-invasive treatment related cardiovascular toxicity in breast cancer
C Li, Huijuan Dai, Xinning Guo, et al.
iScience (2025) Vol. 28, Iss. 4, pp. 111759-111759
Closed Access
Matters of the Heart: Cardiotoxicity Related to Target Therapy in Oncogene-Addicted Non-Small Cell Lung Cancer
Sara Torresan, Martina Bortolot, Elisa De Carlo, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 554-554
Open Access
Sorafenib-induced cardiovascular toxicity: a cause for concern
Zheng Deng, Shuang Xiao, Yingying He, et al.
Chemico-Biological Interactions (2025), pp. 111388-111388
Closed Access
The Application and Molecular Mechanisms of Mitochondria-Targeted Antioxidants in Chemotherapy-Induced Cardiac Injury
Chih-Jen Liu, Lu‐Kai Wang, Fu‐Ming Tsai
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 3, pp. 176-176
Open Access
Necroptotic Suppression of Lung Cancer Cell Proliferation and Migration: A Comprehensive In Vitro and In Silico Study to Determine New Molecular Targets for Pexidartinib
Ebru Hacıosmanoğlu, Dilraj Lama, Hande İpek Yetke, et al.
Cell Biochemistry and Function (2025) Vol. 43, Iss. 3
Closed Access
A high-performance extracellular field potential analyzer for iPSC-derived cardiomyocytes
Nidhi Patel, Alex Shen, Yuko Wada, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Cilostazol alleviates imatinib-induced myocardial injury in rats by modulating the TGF-β1/MAPK, SHC/Grb2/SOS signaling pathways and upregulating miRNA-195-5P
Basel A. Abdel‐Wahab, Ehab A. M. El‐Shoura, Saad Misfer Alqahtani, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Cardiotoxicity induced by xanthatin via activating apoptosis and ERS pathways in zebrafish
Lixin Feng, Liyan Xu, Jing Huang, et al.
Drug and Chemical Toxicology (2025), pp. 1-12
Closed Access
Research Advances in Endoplasmic Reticulum Stress in Cardiovascular Disease
雨晴 陈
Advances in Clinical Medicine (2025) Vol. 15, Iss. 03, pp. 2505-2512
Closed Access
Key Mechanisms of Oxidative Stress-Induced Ferroptosis in Heart Failure with Preserved Ejection Fraction and Potential Therapeutic Approaches
Junling Lin, Bingtao Li, Xueqi Guo, et al.
Reviews in Cardiovascular Medicine (2025) Vol. 26, Iss. 3
Open Access
Controlled release of dasatinib from cyclodextrin-based inclusion complexes by mechanochemistry: A computational and experimental study
Katarina Sokač, Lucija Vrban, Marin Liović, et al.
International Journal of Pharmaceutics (2025), pp. 125552-125552
Closed Access
Overview of Oncology: Drug-Induced Cardiac Toxicity
Nilima Rajpal Kundnani, V Vieira Passini, Iulia Stefania Carlogea, et al.
Medicina (2025) Vol. 61, Iss. 4, pp. 709-709
Open Access
Understanding the Mechanisms of Chemotherapy-Related Cardiotoxicity Employing hiPSC-Derived Cardiomyocyte Models for Drug Screening and the Identification of Genetic and Epigenetic Variants
A Solomon, Swarna Dabral, R. G. Brajesh, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 9, pp. 3966-3966
Open Access
Antineoplastic drugs inducing cardiac and vascular toxicity – An update
Serena Barachini, Sandra Ghelardoni, Zoltán V. Varga, et al.
Vascular Pharmacology (2023) Vol. 153, pp. 107223-107223
Closed Access | Times Cited: 10
Receptor Tyrosine Kinase: Still an Interesting Target to Inhibit the Proliferation of Vascular Smooth Muscle Cells
Yilin Xiong, Yan Wang, Tao Yang, et al.
American Journal of Cardiovascular Drugs (2023) Vol. 23, Iss. 5, pp. 497-518
Closed Access | Times Cited: 7
Cardiovascular Toxicity in Cancer Therapy: Protecting the Heart while Combating Cancer
Amit Manhas, Dipti Tripathi, Dilip Thomas, et al.
Current Cardiology Reports (2024) Vol. 26, Iss. 9, pp. 953-971
Closed Access | Times Cited: 2
Sorafenib induces cardiotoxicity through RBM20-mediated alternative splicing of sarcomeric and mitochondrial genes
Songming Liu, Shanshan Yue, Yuxuan Guo, et al.
Pharmacological Research (2023) Vol. 198, pp. 107017-107017
Open Access | Times Cited: 5
A simple and rapid pre-clinical in vivo model reveals comparative cardiotoxicity profiles of kinase inhibitors
Qudrathulla Khan Quadri Mohammed, Nusrath Banu, Shilpa Reddy Police, et al.
Toxicology and Applied Pharmacology (2024) Vol. 486, pp. 116944-116944
Closed Access | Times Cited: 1
Multikinase inhibitors modulate non-constitutive proteasome expression in colorectal cancer cells
А. В. Буров, Ekaterina Grigorieva, Timofey Lebedev, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 1
Informing Hazard Identification and Risk Characterization of Environmental Chemicals by Combining Transcriptomic and Functional Data from Human-Induced Pluripotent Stem-Cell-Derived Cardiomyocytes
Han‐Hsuan D. Tsai, Lucie C. Ford, Sarah D. Burnett, et al.
Chemical Research in Toxicology (2024) Vol. 37, Iss. 8, pp. 1428-1444
Closed Access | Times Cited: 1
Serum creatine kinase elevation following tyrosine kinase inhibitor treatment in cancer patients: Symptoms, mechanism, and clinical management
Hang Zhang, Kenneth K.W. To
Clinical and Translational Science (2024) Vol. 17, Iss. 11
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top